Clinical trial NCT04592432: Development of an Educational Video Game to Improve Nursing Students' Reasoning With Acute Heart Failure Patients
Official title: Development of a Serious Game to Improve Nursing Students' Clinical Reasoning in the Context of Acute Heart Failure
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Heart Failure
Motivation
Keywords: Clinical reasoning
Intrinsic motivation
Serious gaming
Nursing education
Undergraduate education
Lead sponsor: Université de Montréal
Sponsor class: OTHER
First posted: 2020-10-19
Enrollment: 28
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: The quantitative component is a two-group randomized crossover trial with 1:1 group allocation. Each participant will be randomly allocated to one of the two intervention sequences (i.e., the serious game SIGN@L-A followed by the serious game SIGN@L-B or vice versa). The randomization sequence list will be generated by an individual independent to quantitative data collection using an online program (randomizer.org). The primary investigator will not have access to this list. This individual will inform the primary investigator of participants' allocation after they have consented to be randomized, their randomization order based on the exact time they have completed the online consent form. Block randomization will be used with block sizes of six to avoid imbalances in group sizes.
Primary purpose: OTHER

Brief summary: The aim of this study is to appreciate, using quantitative and qualitative empirical methods, the contribution of an educational video game to the engagement, the motivation, and the development of nursing students' interpretation of acute heart failure patients' health condition. Two prototypes of the same educational video game have been developed. Study participants will play with both prototypes, complete online questionnaires and be interviewed by a research assistant regarding their experience with both prototypes. Study results will serve to select the most promising prototype between the two, based on its potential to support the engagement, the motivation, and the development of nursing students' interpretation of acute heart failure patients' health condition. Study results will also serve to refine the selected prototype before conducting a larger-scale efficacy trial. As such and given the small sample number of participants that is expected, it is not planned to conduct hypothesis testing.


Eligibility criteria: Inclusion Criteria:

* As part of a Bachelor of Nursing program, to be registered in a course in which acute heart failure concepts are a focus.

Exclusion Criteria:

* No exclusion criteria

Primary outcomes:
measure: Engagement with SIGN@L-A
timeFrame: Up to a week after being assigned to SIGN@L-A
measure: Engagement with SIGN@L-B
timeFrame: Up to a week after being assigned to SIGN@L-B
measure: Intrinsic motivation toward SIGN@L-A
timeFrame: Up to a week after being assigned to SIGN@L-A
measure: Intrinsic motivation toward SIGN@L-B
timeFrame: Up to a week after being assigned to SIGN@L-B
measure: Change in clinical reasoning in the context of acute heart failure
timeFrame: At baseline; up to seven days post-randomization
measure: Change in clinical reasoning in the context of acute heart failure
timeFrame: At baseline; between seven and fourteen days post-randomization
Secondary outcomes:
measure: Time spent playing with SIGN@L-A
timeFrame: Up to a week after being assigned to SIGN@L-A
measure: Time spent playing with SIGN@L-B
timeFrame: Up to a week after being assigned to SIGN@L-B
measure: Degree to which the participant would like to play again with SIGN@L-A
timeFrame: Up to a week after being assigned to SIGN@L-A
measure: Degree to which the participant would like to play again with SIGN@L-B
timeFrame: Up to a week after being assigned to SIGN@L-B
measure: Favorite prototype of the serious game
timeFrame: Up to 14 days post-randomization
Other outcomes:
Locations:
city: Montreal
country: Canada
facility: Université de Montréal
state: Quebec
Study officials:
affiliation: Université de Montréal
name: Marc-André Maheu-Cadotte, PhD(c)
role: PRINCIPAL_INVESTIGATOR
affiliation: Université de Montréal
name: Patrick Lavoie, PhD
role: STUDY_DIRECTOR
affiliation: Université de Montréal
name: Véronique Dubé, PhD
role: STUDY_DIRECTOR
References: